MedPath

Serodus AS

๐Ÿ‡ณ๐Ÿ‡ดNorway
Ownership
-
Employees
-
Market Cap
-
Website

SER150 vs Placebo in Diabetic Kidney Disease

Phase 2
Completed
Conditions
Diabetic Kidney Disease
Interventions
Drug: Placebo
First Posted Date
2021-05-11
Last Posted Date
2024-06-21
Lead Sponsor
Serodus AS
Target Recruit Count
20
Registration Number
NCT04881123
Locations
๐Ÿ‡ณ๐Ÿ‡ฟ

Pacific Clinical Research Clinic Rotorua, Rotorua, Bay Of Plenty, New Zealand

๐Ÿ‡ณ๐Ÿ‡ฟ

PCRN Silverdale Medical Centre, Silverdale, Hibiscus Coast, New Zealand

๐Ÿ‡ณ๐Ÿ‡ฟ

New Zealand Clinical Research (NZCR), Christchurch, New Zealand

and more 9 locations

SER100 in Isolated Systolic Hypertension

Phase 2
Completed
Conditions
Isolated Systolic Hypertension
Interventions
Drug: Placebo
First Posted Date
2013-11-19
Last Posted Date
2016-10-20
Lead Sponsor
Serodus AS
Target Recruit Count
17
Registration Number
NCT01987284
Locations
๐Ÿ‡ฌ๐Ÿ‡ง

Northwick Park Hospital, Harrow, Middlesex, United Kingdom

๐Ÿ‡ซ๐Ÿ‡ฎ

FinnMedi Oy/Valkeakoski District Hospital, Tampere, Finland

๐Ÿ‡ซ๐Ÿ‡ฎ

CRST/Turku University Hospital, Turku, Finland

and more 4 locations
ยฉ Copyright 2025. All Rights Reserved by MedPath